Philip Morris
Showdown Over Clear Air Science. Puzzling Over A Potential Killer's Modus Operandi
Fields
- Author
- Kaiser, J.
- Type
- MAGA, MAGAZINE ARTICLE
- Area
- CARCHMAN,RICHARD/OFFICE
- Litigation
- Iwoh/Produced
- Characteristic
- EXTR, EXTRA
- MARG, MARGINALIA
- Site
- R530
- Named Organization
- American Cancer Society
- American Iron + Steel Inst
- American Lung Assn
- Brigham Young Univ
- Ca Epa
- Carnegie Mellon Univ
- Centers for Disease Control + Prevention
- Chemical Industry Inst of Technology
- Columbia Univ
- Commerce Comm
- Congress
- Electric Power Research Inst
- Environmental Health Perspectives
- Epa, Environmental Protection Agency
- Fred Hutchinson Cancer Research Center
- Harvard
- Harvard Team
- Health Canada
- Health Effects Inst
- House
- Industry Group
- Johns Hopkins Univ
- Lovelace Respiratory Research Inst
- Natural Defense Council
- Ny Univ
- Office of Air Quality Planning + Standar
- Resources for the Future
- Robert Wood Johnson Medical School
- Science
- White House
- Yale
- Air Quality Standards Coalition
- American Iron + Steel Inst
- Author (Organization)
- Science
- Named Person
- Bachmann, J.
- Browner, C.
- Burnett, R.
- Clinton
- Dockery, D.
- Florig, K.
- Godelski, J.
- Kinney, P.
- Krupnick, A.
- Lipfert, F.
- Lippman, M.
- Mauderly, J.
- Mcclellan, R.
- Moolgavkar, S.
- Ostro, B.
- Pope, A.
- Samet, J.
- Schwartz, J.
- Stolwijk, J.
- Thurston, G.
- Upton, A.
- Woodruff, T.
- Xxsolomon
- Zelikoff, J.
- Browner, C.
- Master ID
- 2063633486/4072
Related Documents:- 2063633486-4072 Book 7 Tabs 1-68
- 2063633488-3498 Predicting Rodent Carcinogenicity From Mutagenic Potency Measured in the Ames Salmonella Assay
- 2063633500-3505 Workplace Conditions, Socioeconomic Status, and the Risk of Mortality and Acute Myocardial Infarction: the Kuopio Ischaemic Heart Disease Risk Factor Study
- 2063633507-3510 Environmental Exposure to Gasoline and Leukemia in Children and Young Adults - An Ecology Study
- 2063633512-3530 Behavioral Functions of Nucleus Accumbens Dopamine: Empirical and Conceptual Problems with the Anhedonia Hypothesis
- 2063633532-3543 the Use of A Urine Mutagenicity Assay in the Monitoring of Environmental Exposure to Genotoxins
- 2063633545-3553 Smoking and Relative Body Weight: An International Perspective From the Who Monica Project
- 2063633555-3562 Aromatic Amine Dna Adduct Formation in Chronically-Exposed Mice: Considerations for Human Comparison
- 2063633564-3570 Life-Style Factors and Female Infertility
- 2063633571 Sensitivity of the Relation Between Cumulative Magnetic Field Exposure and Brain Cancer Mortality to Choice of Monitoring Data Grouping Scheme
- 2063633573-3584 Genetic Risk Factors for Chronic Obstructive Pulmonary Disease
- 2063633586-3593 Risk Factors Associated with the Development of Peripheral Arterial Disease in Smokers: A Case-Control Study
- 2063633595-3609 Self-Regulation and Mortality From Cancer, Coronary Heart Disease, and Other Causes: A Prospective Study
- 2063633611-3620 Dna Damage in Nasal Respiratory Epithelium From Children Exposed to Urban Pollution
- 2063633622-3630 Co-Carcinogenic Effects of Various Agents in Rats Following Exposure to Radon and Radon Daughters
- 2063633632-3638 Genetics and the Origin of Species: An Introduction
- 2063633640-3647 Subjective Indoor Air Quality in Schools in Relation to Exposure
- 2063633649-3662 the Nurses' Health Study: 20-Year Contribution to the Understanding of Health Among Women
- 2063633664-3671 Polymorphisms of Cyp1a1 and Gstm1 Influence the in Vivo Function of Cyp1a2
- 2063633673-3677 Quantitative Evaluation of Multiplicity in Epidemiology and Public Health Research
- 2063633679-3681 Abc of Allergies Asthma and Allergy
- 2063633683-3684 Inflammatory Responses and Coronary Heart Disease the 'dirty Chicken' Hypothesis of Cardiovascular Risk Factors
- 2063633685 Consultant Suspended for Not Getting Consent for Cardiac Procedure. Mmr Vaccine Policy Is Backed
- 2063633687-3690 When Can Odds Ratios Mislead?
- 2063633692-3699 Increased Responsiveness of Ventral Tegmental Area Dopamine Neurons to Glutamate After Repeated Administration of Cocaine or Amphetamine Is Transient and Selectively Involves Ampa Receptors
- 2063633701-3703 Association Between Cigarette Smoking and Fhit Gene Alterations in Lung Cancer
- 2063633705-3712 Genetic Testing for Susceptibility to Adult - Onset Cancer the Process and Content of Informed Consent
- 2063633714-3721 Release of Carbon Granules From Cigarettes with Charcoal Filters
- 2063633723-3731 Detection of Low - Fraction K-Ras Mutations in Primary Lung Tumors Using A Sensitive Method
- 2063633733-3740 Socioeconomic Level, Sedentary Lifestyle, and Wine Consumption As Possible Explanations for Geographic Distribution of Cerebrovascular Disease Mortality in Spain
- 2063633742-3750 Air Pollution and Daily Admissions for Chronic Obstructive Pulmonary Disease in 6 European Cities: Results From the Aphea Project
- 2063633751 Airway Obstruction and Rheumatoid Arthritis
- 2063633753-3756 Relationship Between Acetylator Status, Smoking, Diet and Colorectal Cancer Risk in the North-East of England
- 2063633758-3763 Cardiovascular Risk Factor Profile in Subjects with Familial Predisposition to Myocardial Infarction in Denmark
- 2063633765-3770 Effect of Fresh Fruit Consumption on Lung Function and Wheeze in Children
- 2063633772-3777 Interactive Effect of the P53 Gene and Cigarette Smoking on Coronary Artery Disease
- 2063633779-3784 P53 Gene Aberrations in Non-Small-Cell Lung Carcinomas From A Smoking Population
- 2063633786-3794 Interlaboratory Comparison of Pm10 and Black Smoke Measurements in the Peace Study
- 2063633796-3799 Statistical Significance - A Misconstrued Notion in Medical Research
- 2063633801-3808 Urinary 1-Hydroxypyrene As A Marker of Exposure to Pyrene: An Epidemiological Survey on A General Population Group
- 2063633810-3813 Genetic Polymorphism of Cytochrome P450 As A Biomarker of Susceptibility to Environmental Toxicity
- 2063633815-3824 Smoking Among Psychiatric Patients
- 2063633826-3831 Evaluation of Certain Risk Factors for Lung Cancer in Cracow (Poland)
- 2063633833-3840 Prevalence and Predictive Value of P53 Mutation in Patients with Oesophageal Squamous Cell Carcinomas: A Prospective Clinico-Pathological Study and Survival Analysis of 70 Patients
- 2063633842-3848 Ki-Ras Mutations in Exocrine Pancreatic Cancer: Association with Clinico-Pathological Characteristics and with Tobacco and Alcohol Consumption
- 2063633850-3859 Risk Factors for Raynaud's Phenomenon Among Workers in Poultry Slaughterhouses and Canning Factories
- 2063633861-3880 Molecular Events in Lung Carcinogenesis
- 2063633882-3885 Cyp1a1, Cyp2e1 and Gstm Polymorphisms Are Not Associated with Susceptibility to Squamous - Cell Carcinoma of the Esophagus
- 2063633887-3891 the P53 Tumor Suppressor Targets A Novel Regulator of G Protein Signaling
- 2063633893-3896 New Tumor Suppressor Found - Twice. Prepaper Publicity Ignites Race to Publish. Shape- Changing Crystals Get Shiftier
- 2063633898-3899 Who Reform and Global Health
- 2063633905-3910 Polymorphisms in the Glutathione S-Transferase Class Mu and Theta Genes Interact and Increase Susceptibility to Lung Cancer in Minority Populations (Texas, United States)
- 2063633912-3927 Plant Foods and Colon Cancer: An Assessment of Specific Foods and Their Related Nutrients (United States)
- 2063633929 Smoking, Alcohol and Coffee Consumption, and H Pylori Infection
- 2063633931-3934 Grand Rounds at the Clinical Center of the National Institutes of Health Evaluating Coronary Heart Disease Risk Tiles in the Mosaic
- 2063633936-3939 New Clues to Asthma Therapies. Why the Rise in Asthma Cases? New Lead to Safer Marrow Transplants
- 2063633941-3946 Cancer Undefeated
- 2063633948-3964 Lung Tissue Responses and Sites of Particle Retention Differ Between Rats and Cyanomolgus Monkeys Exposed Chronically to Diesel Exhaust and Coal Dust
- 2063633966-3986 Implementation on Epa Revised Cancer Assessment Guidelines: Incorporation of Mechanistic and Pharmacokinetic Data
- 2063633988-3999 Particle Pollution and Sudden Infant Death Syndrome in the United States Policy Memorandum
- 2063634001-4007 Neighborhood Social Environments and the Distribution of Low Birthweight in Chicago
- 2063634009-4014 the Effects of Cigarette Smoking and Gestational Weight Change on Birth Outcomes in Obese and Normal-Weight Women
- 2063634016-4017 Annotation: Cigarette Smoking, Nutrition, and Birthweight
- 2063634019-4020 Helicobacter Pylori Infection and Coagulation in Healthy People
- 2063634022-4023 Prospective Study of Helicobacter Pylori Seropositivity and Cardiovascular Diseases in A General Elderly Population
- 2063634025-4027 Age Specific Trends in Asthma Mortality in England and Wales, 830000 - 950000: Results of An Observational Study
- 2063634029-4036 Childhood Leukemia and Electromagnetic Fields: Results of A Population - Based Case - Control Study in Germany
- 2063634038-4047 Association of Smoking, Body Mass, and Physical Activity with Risk of Prostate Cancer in the Iowa 65+ Rural Health Study (United States)
- 2063634049-4056 Tobacco and Non-Hodgkin's Lymphoma: Combined Analysis of Three Case-Control Studies (United States)
- 2063634058-4063 How Much Pain for Cardiac Gain?
- 2063634065-4071 A Prospective Study of Body Mass Index, Weight Change, and Risk of Stroke in Women
- Date Loaded
- 07 Jun 1999
Document Images
NEWS & COMMENT=
Showdown Over Clean Air Science
Industry and environmental researchers are squaring off over studies linking air pollution and
illness in
what some are calling the biggest environmental fight of the decade
Nine years ago, epidemiologist Joel Schwartz
stumbled across a disturbing pattern of
death. Schwartz, then at the Environmental
Protection Agency (EPA), noted that when
soot levels in the air of Steubenville, Ohio,
rose on any given day in the 1970s and 1980s,
the number of fatalities among residents would
jump the next day--even when air pollution
levels were supposedly safe. Schwartz went
on to document the same chilling pattern in
four more cities that track soot: Philadel-
phia; Detroit; St. Louis; and Kingston, Ten-
nessee. Projecting these findings to the en-
tire U.S. population, Schwartz estimated
that 60,000 people c.ould be dying each
year--more .than the annual number of car
crash victimsufrom heart and lung diseases
aggravated by tiny airborne par-
ticles. At scientific meetings in
1991 and 1992, recalls Schwartz,
now at Harvard, the studies got "a
tremendous amount of attention."
Today, the analysis is provoking
a furor. Schwartz's findings and
similar studies by other researchers
lit the fuse of a political powder keg:
a debate over whether industry
should take costly steps to reduce
the amount of soot and other pol-
lutants released into the atmo-
sphere. Heeding the results from
Schwartz and others, on 16 July
the EPA unveiled final rules de-
signed to tighten ozone standards
and clamp down on particles. The
cost of implementing the rules--
which EPA estimates at $9.7 bil-
lion per year for measures such as
installing new equipment on power
plants and diesel trucks--has
sparked a fierce protest on Capitol Hill from
industry groups and many state and local
officials. So far, EPA has stood its ground.
The agency has refused to scale back the
standards, first proposed in November, and
President Clinton has said he supports
them. But now the bell has sounded for round
two of what is shaping up to be the biggest
environmental fight of the decade: Con-
gress is about to consider legislation that
would quash the standards.
Opponents argue that the science fails
to support the new regulations, which
would lower maximum ozone levels by a
third and, for the first time, set acceptable
airborne levels of fine particles less than
S ELECTED PARTICLE-POLLUTION STU DI ES
466
2063633901
2.5 micrometers in diameter, called PM2.s,
which are generated mainly by burning fos-
sil fuels. Although industry groups have
sharply criticized the new ozone standards,
arguing that the health benefits would be
marginal compared to the costs, most of
the scientific debate has centered on the
limits on particulate matter.
Critics charge that Schwartz's popula-
tion studies and others like it do not link
individual pollutants to human health ef-
fects; instead, they argue, different factots--
such as other pollutants and lifestyle fac-
tors--may be responsible for the increased
death rate. Moreover, scientists have yet to
propose a plausible explanation for how fine
particles might harm the body (see sidebar
health effects in scores of cities, says John
Bachmann, associate director for science
policy in EPA's Office of Air Quality Plan-
ning and Standards. EPA acknowledges,
however, that many questions remain about
how fine particles cause harm. "All of us
agree we need way more science," says
Bachmann. However, he says, "We're not
supposed to wait until people are dead in
the streets." But many scientists say the
problem is not the standard itself, but the
levels EPA has chosen. "These studies can't
readily lead to a specific number," says Johns
Hopkins University epidemiologist Jona-
than Samet. "It all makes sense to regulate
PMz.5. The question is, do we have the quan-
titative information to do it? That's where
the debate begins."
Study
Design Kay Findings
Utah Valley
(Pope et aL,
1989)
Philadelphia
(Schwartz
& Dockery,
1992)
Hospital admissions
& PMIo levels across
period encompassing
13-month shutdown
of steel mill
Daily mortality
and total PM
levels
Admissions for
respiratory disease
higher when mill
operating
Significant association,
with greater risks for
elderly and for death
from chronic obstructive
pulmonary disease
Six Cities Interviewed 8111 26% higher death rate
(Dockery people for lifestyle in most polluted vs.
et aL, 1993) factors and tracked least polluted city
deaths over 14 to 16
yrs.; used several
PM measures
American Used health infor- 17% higher death rate
Cancer Society mation from in most polluted vs.
151 cities 552,138 ACS least polluted city
(Pope et aL, volunteers, PM2.s
1995) for 50 cities
on p. 469). Because of such shortcomings,
the Air Quality Standards Coalition, rep-
resenting 500 petroleum, automotive, and
other industry and business groups, derides
the science as "totally inadequate." Adds
epidemiologist Suresh Moolgavkar of the
Fred Hutchinson Cancer Research Center
in Seattle, "EPA is espousing a certainty in
its language that is simply not justified by
the data."
But EPA Administrator Carol Browner
contends that there are plenty of data to
support the rule, even the particularly con-
tentious PMz.5 standard. The evidence comes
from more than 60 published health studies
that show a link between soot and adverse
Fine particle distinctions
Researchers have been well aware of
the dangers of particles ever since
several disastrous air pollution epi-
sodes in Europe and the United
States in the middle of this cen-
tury, such as a deadly week in Lon-
don in 1952 when choking soot and
sulfur dioxide--at least 10 times
today's average levels---killed thou-
sands, mostly children and elderly
people with heart or lung ailments.
Such incidents spurred controls on
pollutants. Since 1971, EPA has
ordered limits on levels of par-
ticles, which are composed of dust
from soils, bits of carbon spewed by
diesel vehicles and power plants,
sulfates, and gases such as nitrogen
oxides and volatile organics that
condense onto seed particles. Ini-
tially, hese rules covered particles up to 50
micrometers in diameter. But after studies
showed that coarse particles tend to be
safely expelled from the body's upper air-
ways, the agency in 1987 restricted only
finer particles, less than 10 micrometers in
diameter (PM~0).
By the early 1990s, however, $chwartz's
study and dozens like it had convinced many
experts that the PM~0 standard might not be
protective enough, especially for the elderly,
children, people with frail immune systems,
and other vulnerable groups. In cities in the
United States and other countries, death
rates and hospital admissions for people suf-
fering from cardiac problems and respiratory
. SCIENCE • VOL. 277 • 25JULY 1997 • www.sciencema~.org

problems such as asthma seemed to rise and
fall with daily particle levels. For example, a
study led by biostatistician Richard Burnett
of Health Canada found that in Ontario in
the mid-1980s, for every 13 micrograms/
meted rise in daily levels ofsulfater~a surro-
gate for overall PM2.5--hospital admissions
for respiratory and cardiac events shot up
3.7% and 2.8%, respectively.
Researchers also began to recognize that
they needed to focus on finer particlesm
PMz.5 or smaller--because
animal studies using radioac-
tively tagged particles and
lung casts made from human
cadavers had shown that
such tiny particles are most
likely to lodge deep in lungs.
"The finer particles repre-
sent a completely different
class of materials than the
coarser PMI0, and it is logical
that they probably have dif-
ferent activities and types of toxicity," says
toxicologist Joseph Mauderly of the Love-
lace Respiratory Research Institute in Al-
buquerque, New Mexico. The PMm is mostly
inert crustal dust, while the combustion-
generated fine particles contain the nasty
stuff--corrosive acids and metals--that can
damage tissues.
Many experts, however, were skeptical of
these red flags. Their main beef was th~at the
daily mortality studies were unable to discern
whether air pollution levels were signifi-
cantly shortening lives or perhaps hastening
by hours or days the deaths of very sick
people already on the verge of dying. "People
believed the studies were picking up a real
phenomenon, but the interpretation was
unclear," says Columbia University epidemi-
ologist Patrick Kinney.
A more convincing set of findings came
along in 1993, however, when a Harvard
team headed by Douglas Dockery examined
soot and other pollutant levels and 1429
deaths that occurred in 8111 adults the team
followed for 14 to 16 years in six Eastern U.S.
cities (known as the Six Cities study). The
researchers interviewed subjects about weight,
smoking, and other risk factors, correcting
for these lifestyle differences, which had not
been possible in earlier studies comparing
city death rates. They found that the stron-
gest association bet~veen any pollutant and
death rates was with fine particles, and that
the risk of death was 26% higher in the most
polluted city--Steubenvitle--compared to
the cleanest--Portage, Wisconsin. The re-
sults supported the findings of the daily stud-
ies and raised additional concerns by suggest-
ing that the harmful effects of particles can
build up over years.
A second long-term study 2 years later
strengthened the case against airborne par-
tides. Tapping an American Cancer Soci-
ety (ACS) database of smoking, age, occu-
pation, diet, and other data on over 550,000
volunteers in 151 cities, along with sulfate
data and PM2.~ readings for 50 cities, the
Harvard group and environmental econo-
mist Arden Pope of Brigham Young Univer-
sity in Provo, Utah, found a 17% difference
over 8 years in death rates between the
cleanest and dirtiest cities. "We're not
likely to see/t study of this quality and mag-
"It is impossible to
say one component
is any more
responsible than
any other."
mSuresh Moolgavkar
nitude [again] in our lifetimes,"says Alan
Krupnick, an economist with Resources for
the Future, a W~shington, D.C., think tank.
"I think that pushed a lot of people over
the edge," adds Kinney.
A Natural Resources Defense Council
study extrapolated the results and came up
with 64,000 annual deaths that were up to 2
years premature. Using this "body count"
and its own analyses, EPA estimates that its
regulations will prevent 15,000 premature
deaths each year and 9000 hospital admis-
sions, for a total estimated cost savings ors 19
billion to $104 billion a yearmabout two to
12 times the estimated cost of compliance.
Industry chokes on rules
After a 1993 lawsuit brought by the Ameri-
can Lung Association forced EPA to stick to
its mandated 5-year schedule for reviewing
"This whole industry
argument that it's all
other pollutants is
just not supported by
the data."
m Joel
the latest evidence of particle health effects,
critics of the science behind the new rules
launched their assault. "We'd go to meetings
and testify at hearings," says Dockery, "and
they'd say, 'We get different results.'"
Critics have saved most of their barrage
for the mortality studies. Hutchinson's Mool-
gavkar, for instance, reanalyzed Schwartz's
Philadelphia data on behalf of the American
Iron and Steel Institute. When Moolgavkar
took into account other air pollutants--
ozone and nitrogen dioxide--and analyzed
them all simultaneously, it was impossible to
separate the health effects of particles from
those of sulfur dioxide. "It is impossible to say
one component is any more responsible than
any other," says Mootgavkar.
Others point out that the long-term ACS
and Six Cities studies captured only a frac-
tion of the total pollution the subjects were
exposed to over their lives. "How does that
relate to what people are exposed to across
their lifetimes? We really don't know," says
Samet of Johns Hopkins, who nonetheless
says he believes the link between daily mor-
tality and particles is real. Biostatistician
Fred Lipfert, a consultant who has worked for
the Electric Power Research Institute in Palo
Alto, California, also argues that the Har-
vard team "kind of just took a first cut at
socioeconomic status," and that a more sed-
entary lifestyle in, say, Steubenville com-
pared to Portage might account for the differ-
ences in mortality that the Six Cities study
attributes to fine particles.
Other concerns center on how EPA esti-
mated the potency of these tiny particles.
Because only a few excess deaths and hospi-
talizations occur when the air contains low
levels of particle pollution, the studies lack
the statistical power to precisely estimate
how dangerous particles are at these levels.
So EPA assumed that the health threat in-
creases in a linear fashion with dose, ignor-
ing the possibility that the risk may taper off
at lower levels. Adding to the uncertainty,
few studies actually measured PM2.5--most
used PMm or a surrogate such as sulfates.
"There's very little information on the ra-
tio" between PMt0 and PMz.5, says Yale epi-
demiologist Jan Stolwijk.
Moreover, without knowing what it is
about particles that causes ill heakh effects,
it's impossible to be sure that
the regulations are targeting
the right source, says toxicolo-
gist Roger McClellan, presi-
dent of the Chemical Industry
Institute of Technolog~ in Re-
search Triangle Park, North
Carolina. For example, he says,
a state might target diesel en-
gines or clamp down on plow
Sc[1wart::~ dust, when the problem is actu-
ally sulfates from power plants.
Says McClellan: "We run a real hazard here
of putting in place a new standard that we
don't know how effective it will be."
A lot of hot air?
EPA scientists disagree, saying they are con-
fident that the science supports their regula-
tions. "We think we've done a totally legiti-
mate, rational analysis of the studies we had,"
says the agency's Bachmann. He points to

Puzzling Over a Potential Killer's Modus Operandi
Experts may clash over the strength of the science behind the
new clean air regulations (see main text), but they do agree on one
thing: It's still a mystery how airborne particles could trigger a
bout of asthma or cause someone to drop dead of a heart attack. A
dozen labs are now racing to find a modus operandi. ~
This is not the first time that an unknown mechanism has
bedeviled researchers trying to assess a potential environmen-
tal hazard. But unlike some other alleged risks--such as elec-
tromagnetic fields--it's apparent that the more particles one
breathes, the greater the danger, says Keith Florig, a science
policy expert at Carnegie Mellon University in Pittsburgh. "If
you observe a strong enough dose response, that's pretty com-
pelling," he says.
PMm for 6 hours per day for three straight days, 37% of the
bronchitic animals died; all the healthy rats survived.
Godleski has also tightened balloons around the coronary
arteries of dogs to simulate angina, or cardiac chest pain, theft
exposed the dogs for 6 hours to PMz.5. At particle concentrations
of about 116 tig/m3 and 175 gg/m3, levels often reached in heavily
polluted cities, the dogs' hearts developed arrhythmias that are
commonly observed in people nearing a fatal heart attack. God-
leski says these animal studies could help explain the observation
that when particle pollution soars, "a lot of people are dying
outside of the hospital. These could very well be sudden deaths"
from heart attacks, he says.
Now that researchers have potential animal models for the
The best way to unravel a pollutant's mechanism is to study how
it triggers health effects in animals. Until recently, however, re-
searchers had drawn a blank. "I've done lots of studies" exposing
healthy mrs to diesel soot for nearly their entire lives at particle levels
more than 10 times what people typically encounter, and "nothing
happens," says toxicologist Joseph Mauderly of the Lovelace Res-
piratory Research Institute in Albuquerque, New Mexico.
But in a parallel to the epidemiological studies that first drew.
attention to the hazards of airborne particles, toxicologists in the
last year or two have begun to find that sickly animals exposed to
fine particles get sicker and-sometimes die. For example, pulmo-
nary biologist John Godleski of the Harvard School of Public
Health in Boston found that rats with chronic bronchitis are
especially vulnerable. '~¢;hen he exposed the animals to particles
smaller than 2.5 micrometers (PMz.5) strained from Boston air, at
levels equivalent toabout twice the current'EPA daily limit for
health effects, they are trying to sort out whether a particle's
chemical composition dictates how dangerous it is, and how it
triggers health effects. "Nobody is sure what it is in, or on, or of
khe particles" that causes health effects, notes toxicologist
Judith Zelikoff of. New Ydrk University School of Medicine.
Freshly created particles appear to be more toxic than aged
particles, so the culprit may be some reactive chemical groupm
such asan acid, a metal, an organic compound, or a peroxide--
attached to a particle'ssurface, says Morton Lippman, also at
New york University School of Medicine. Others think that
ultrafine particles, or those less than 0.1 micrometer in diam-
eter, are the problem, because they are much more potent than
larger particles at provoking immune responses in the lungs. "The
problem is, none of these hypotheses really seems to be a solid
explanation for all the effects," Mauderly says. "Probably they
all contribute.'? , . .; ~-J .K.
what he calls "overwhelming consistency"--
more than 60 of 86 population studies linked
health effects to fluctuations in particulate
matter levels and the coherence between
deaths, hospitalization, and respiratory dis-
ease. Others point to a study published this
month in Environmental Health Perspectives
by EPA researcher Tracey Woodruffand col-
leagues at the Centers for Disease Control
and Prevention in Atlanta. They found that
infants in cities with high particle pollution
levels are 25% more likely to die of sudden
infant death syndrome than are those in cit-
ies with relatively clean air. "It certainly adds
support," says California EPA epidemiologist
Bart Ostro.
Schwartz also takes aim at the argument
that pollutants other than particles may be
blurring the picture. Cities with only one or
two major airborne pollutants--such as
Santa Clara, California, which has low air
levels of sulfur dioxide and ozone in winter--
still show a link between particle levels and
health problems, he says. "This whole in-
dustry argument that it's all other pollut-
ants is just not supported by the data," says
Schwartz. New York University School of
Medicine epidemiologist George Thurston
says "it's a valid criticism" that some of the
Harvard daily city studies underestimated
the effects of other pollutants, but those con-
tributions "just reduce" the estimated danger
levels of particles. "It doesn't make [the ef-
fects] go away." Finally, Bachmann says,
even ff PM2.5 itself is not the bad guy--if
sulfates alone are the problem, for example---
targeting it should also control whatever pol-
lutant is taking lives.
Most experts contacted by Science agreed
that EPA was justified in setting a standard
for PMz.s. "There's enough circumstantial
evidence that it does make sense to begin
to look at and regulate fine particles as a
class," says Mauderly. At a minimum, Mau-
derly and others add, setting a standard
will force the states to collect data that
could help pin down PM2.s health effects.
But they split on just how stringent that
standard should be. "We have a tremen-
dous amount of uncertainty as to what the
dose-effect relationship is--how dangerous
particles might be and under what circum-
stances," says Mauderly. "The scientific ba-
sis for [EPA's planned levels] is totally lack-
ing," Stolwijk says. "You have to make sev-
eral leaps of faith."
Yet while the studies "have their limita-
tions," says environmental health scientist
Arthur Upton of the Robert Wood Johnson
Medical School in Piscataway, New Jersey,
"I'm not aware that we can dismiss their find-
ings'as unimportant or irrelevant." Deciding
whether to set a stringent standard, Upton
says, "becomds a value judgment. It's not a
scientific question .... Do we dismiss the data?
Or do we accept them as warning signs and
act accordingly?"
EPA's judgment won't be the final word.
The House Commerce Committee is con-
sidering a bill that would impose a 4-year
moratorium on the standards while EPA
does more monitoring and research. Con-
gress may also try to kill the rules through a
new law passed last year to shield small busi-
nesses from overly burdensome regulations.
And the White House announced last month
that EPA will conduct another scientific
review, starting this year, before it imple-
ments the PMz.5 standard. Congress is ex-
pected to set aside up to $35 million next
year in EPA's budget for research on par-
ticles. And Upton is heading a reanalysis of
the Six Cities and ACS studies by the Health
Effects Institute, an industry- and EPA-
funded research organization in Cambridge,
Massachusetts. "It's a vexing question, and I
wish I were Solomon and knew exactly
what the right answer was," Upton says.
"But we'll work on it."
-Jocelyn Kaiser
www.sciencemag.org • SCIENCE • VOL. 277 ° 25 JULY 1997
469
